These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34544978)
1. Serum Angiopoietin-Like Protein 2 and NT-Pro BNP Levels and Their Associated Factors in Patients with Chronic Heart Failure Participating in a Phase III Cardiac Rehabilitation Program. Tanaka C; Kurose S; Morinaga J; Takao N; Miyauchi T; Tsutsumi H; Shiojima I; Oike Y; Kimura Y Int Heart J; 2021 Sep; 62(5):980-987. PubMed ID: 34544978 [TBL] [Abstract][Full Text] [Related]
2. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
3. NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure. Parovic M; Okwose NC; Bailey K; Velicki L; Fras Z; Seferovic PM; MacGowan GA; Jakovljevic DG ESC Heart Fail; 2019 Apr; 6(2):449-454. PubMed ID: 30788904 [TBL] [Abstract][Full Text] [Related]
4. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function. Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990 [TBL] [Abstract][Full Text] [Related]
5. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle. Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738 [TBL] [Abstract][Full Text] [Related]
6. Myocardial strain may predict exercise tolerance in patients with reduced and mid-range ejection fraction. Tsougos E; Angelidis G; Gialafos E; Tzavara C; Tzifos V; Tsougos I; Georgoulias P Hellenic J Cardiol; 2018; 59(6):331-335. PubMed ID: 29203160 [TBL] [Abstract][Full Text] [Related]
7. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study. Nah EH; Kim SY; Cho S; Kim S; Cho HI BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928 [TBL] [Abstract][Full Text] [Related]
8. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction. Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148 [TBL] [Abstract][Full Text] [Related]
9. Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure? Meyer T; Schwaab B; Görge G; Scharhag J; Herrmann M; Kindermann W Z Kardiol; 2004 Jul; 93(7):540-5. PubMed ID: 15243765 [TBL] [Abstract][Full Text] [Related]
10. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415 [TBL] [Abstract][Full Text] [Related]
11. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction. Zhang Y; Li SY; Xie JJ; Wu Y Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277 [TBL] [Abstract][Full Text] [Related]
12. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure]. Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610 [TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355 [TBL] [Abstract][Full Text] [Related]
15. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice]. Zhang QY; Du JB; Chen YH; Li WZ Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452 [TBL] [Abstract][Full Text] [Related]
17. Correlation of N-terminal pro-B-type natriuretic peptide with clinical parameters in patients with hypertension. Pejović J; Ignjatović S; Dajak M; Majkić-Singh N; Vucinić Z; Pavlović M Vojnosanit Pregl; 2013 Aug; 70(8):728-34. PubMed ID: 24069820 [TBL] [Abstract][Full Text] [Related]
18. Association between direct measures of body composition and prognostic factors in chronic heart failure. Oreopoulos A; Ezekowitz JA; McAlister FA; Kalantar-Zadeh K; Fonarow GC; Norris CM; Johnson JA; Padwal RS Mayo Clin Proc; 2010 Jul; 85(7):609-17. PubMed ID: 20592169 [TBL] [Abstract][Full Text] [Related]
19. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980 [TBL] [Abstract][Full Text] [Related]
20. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]